Charcot neuro-osteoarthropathy (CNO), often called the Charcot foot, is one of the most under-recognized complications of diabetes. It is a progressive condition in which bones and joints in the insensate foot weaken, fracture, and dislocate, frequently with little or no pain to warn the patient. Because the early signs mimic more common problems such as cellulitis, gout, or a sprain, the diagnosis is often delayed by weeks or months. That delay matters: an inflamed, structurally unstable foot can collapse into a fixed deformity that leads to ulceration, infection, and, in the worst cases, amputation. This article reviews what recent peer-reviewed literature tells us about recognizing and managing active Charcot neuro-osteoarthropathy.
Why Charcot Develops in the Diabetic Foot
Charcot neuro-osteoarthropathy occurs almost exclusively in people who have lost protective sensation, most commonly from diabetic peripheral neuropathy. When pain feedback is absent, repetitive trauma and an exaggerated local inflammatory response combine to drive bone resorption and joint destruction. The first International Working Group on the Diabetic Foot (IWGDF) guideline dedicated to this condition, published by Wukich and colleagues in 2023, emphasizes that the active phase is fundamentally an inflammatory process and that interrupting it early is the single most important determinant of long-term function.
Recognizing the Active Phase
The hallmark of active Charcot is a warm, red, swollen foot in a person with neuropathy and intact skin, often without significant pain and frequently following minor or unremembered trauma. A systematic review by Raspovic and colleagues (2023) found that the diagnosis rests primarily on clinical examination supported by imaging, and that a skin-temperature difference between the affected and unaffected foot is a useful and reproducible sign of active disease. Plain radiographs may appear normal early, so magnetic resonance imaging is often required to detect bone marrow edema and subtle fractures before deformity develops.
The review also highlighted a persistent gap in the evidence: there is no single laboratory test that confirms the diagnosis, and the distinction between Charcot and infection (osteomyelitis) can be especially difficult when an ulcer is present. Clinicians are therefore advised to maintain a high index of suspicion, as Schweitzer and Rockhill noted in their 2022 review of conservative management, treating any warm, swollen neuropathic foot as Charcot until proven otherwise.
Offloading and Immobilization: The Cornerstone of Treatment
Once active Charcot is suspected, the priority is to remove mechanical stress from the foot and allow the inflammatory process to settle. The accepted standard of care is immobilization in a total contact cast, a well-molded cast that distributes pressure across the entire plantar surface. Immobilization continues until the affected bones and joints have consolidated, a process that can take several months and is monitored through resolution of warmth, swelling, and temperature asymmetry.
An interesting clinical question is whether patients must remain strictly non-weight-bearing during this period. A 2024 systematic review by Prem and colleagues examined weight-bearing versus non-weight-bearing total contact casting and found limited evidence to support the traditional insistence on non-weight-bearing. Across the included studies, allowing carefully selected patients to bear weight in a cast did not appear to compromise healing, while offering meaningful advantages for mobility, independence, and quality of life. The authors called for randomized trials to settle the question, but the finding underscores that rigid protocols should be balanced against patient function.
When Deformity and Ulceration Follow
If active Charcot is missed or treatment is interrupted, the foot can heal in a deformed position, classically a “rocker-bottom” collapse of the midfoot. These bony prominences concentrate pressure and become high-risk sites for plantar ulceration. Velasco-Rodríguez-Rabadán and colleagues (2023), in a systematic review of offloading devices, reaffirmed that the total contact cast remains the most effective method for offloading active plantar ulceration, reinforcing the central role of pressure redistribution across the spectrum of diabetic foot disease. When deformity becomes severe or recurrent ulcers cannot be controlled with offloading and bracing, reconstructive orthopaedic surgery may be considered to restore a stable, plantigrade foot, though this is reserved for selected cases after the active phase has resolved.
Key Takeaways
Charcot neuro-osteoarthropathy is a medical urgency disguised as a minor problem. The current evidence points to several consistent themes: protective sensory loss is the common denominator; a unilaterally warm, swollen foot in a neuropathic patient should be treated as active Charcot until imaging proves otherwise; and prompt immobilization in a total contact cast remains the cornerstone of care. Emerging evidence suggests weight-bearing protocols can sometimes be individualized without sacrificing healing. Above all, early recognition is what separates a foot that recovers a functional shape from one that collapses into chronic ulceration and possible amputation.
References
Wukich DK, Schaper NC, Gooday C, et al. Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023). Diabetes/Metabolism Research and Reviews. 2023;40(3):e3646.
Raspovic KM, Schaper NC, Gooday C, et al. Diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus: A systematic review. Diabetes/Metabolism Research and Reviews. 2023;40(3):e3653.
Prem R, Vignaraja V, Lewis T, Budair B. Weight bearing versus non-weight bearing total contact cast in the management of active Charcot foot: A systematic review. SAGE Open Medicine. 2024;12:20503121241306957.
Schweitzer M, Rockhill S. Conservative Management of Charcot Neuroarthropathy. Clinics in Podiatric Medicine and Surgery. 2022;39(4):585-594.
Velasco-Rodríguez-Rabadán S, Tardáguila-García A, Sanz-Corbalán I, García-Madrid M, López-Moral M, Lázaro-Martínez JL. Effectiveness of Off-Loading Devices in Patients With Active Diabetic Foot Ulcer: A Systematic Review. The International Journal of Lower Extremity Wounds. 2023;24(4):887-893.
Comments
